Symphony Financial, Ltd. Co.
Source: SEC Form 13F · as of Mar 2026Symphony Financial, Ltd. Co. holds 21 biotech & pharma companies tracked by BioSniper, totaling $38.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$38.5M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 41,665 | $10.1M |
| LLYELI LILLY & Co | 6,343 | $5.8M |
| ABBVAbbVie Inc. | 24,387 | $5.3M |
| MRKMerck & Co., Inc. | 35,213 | $4.2M |
| AMGNAMGEN INC | 8,376 | $2.9M |
| PMPhilip Morris International Inc | 13,831 | $2.3M |
| ABTABBOTT LABORATORIES | 15,538 | $1.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,501 | $1.2M |
| PFEPFIZER INC | 36,980 | $1.0M |
| BMYBRISTOL MYERS SQUIBB CO | 13,766 | $832K |
| CAHCardinal Health Inc. | 3,410 | $712K |
| GMOptec International, Inc. | 4,856 | $361K |
| GILDGILEAD SCIENCES, INC. | 2,528 | $348K |
| REGNREGENERON PHARMACEUTICALS, INC. | 404 | $312K |
| PRGOPERRIGO Co plc | 29,918 | $303K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 615 | $273K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,424 | $241K |
| MCKMcKesson Corporation | 269 | $232K |
| SNYSanofi | 4,505 | $214K |
| ELVElevance Health Inc. | 693 | $202K |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 10,017 | $34K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.